Guangzhou Boji Medical and Biotechnological Co Ltd Asset Resilience Ratio

Latest as of March 2026: 13.78%

Guangzhou Boji Medical and Biotechnological Co Ltd asset resilience ratio. Guangzhou Boji Medical and Biotechnological Co Ltd (300404) has an Asset Resilience Ratio of 13.78% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Guangzhou Boji Medical and Biotechnologi to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥230.34 Million

≈ $33.71 Million USD Cash + Short-term Investments

Total Assets

CN¥1.67 Billion

≈ $244.53 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio of Guangzhou Boji Medical and Biotechnological Co Ltd (2015–2025)

Asset resilience ratio of Guangzhou Boji Medical and Biotechnological Co Ltd from 2015 to 2025. This chart shows how Guangzhou Boji Medical and Biotechnological Co Ltd's Asset Resilience Ratio has changed over time. Read how much debt does Guangzhou Boji Medical and Biotechnologi carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Guangzhou Boji Medical and Biotechnological Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Guangzhou Boji Medical and Biotechnologi's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥230.34 Million	13.78%
Total Liquid Assets	CN¥230.34 Million	13.78%

Asset Resilience Insights

Moderate Liquidity: Guangzhou Boji Medical and Biotechnological Co Ltd has 13.78% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Guangzhou Boji Medical and Biotechnological Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangzhou Boji Medical and Biotechnological Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Guangzhou Boji Medical and Biotechnological Co Ltd Asset Resilience Ratio by Year (2015–2025)

Guangzhou Boji Medical and Biotechnological Co Ltd asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Guangzhou Boji Medical and Biotechnological Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	3.40%	CN¥55.37 Million ≈ $8.10 Million	CN¥1.63 Billion ≈ $238.44 Million	+1.77pp
2024-12-31	1.63%	CN¥23.68 Million ≈ $3.46 Million	CN¥1.45 Billion ≈ $212.27 Million	+1.12pp
2023-12-31	0.52%	CN¥7.38 Million ≈ $1.08 Million	CN¥1.43 Billion ≈ $209.10 Million	-3.09pp
2022-12-31	3.61%	CN¥45.69 Million ≈ $6.69 Million	CN¥1.27 Billion ≈ $185.17 Million	+1.85pp
2021-12-31	1.76%	CN¥20.00 Million ≈ $2.93 Million	CN¥1.14 Billion ≈ $166.56 Million	-6.41pp
2018-12-31	8.17%	CN¥49.50 Million ≈ $7.24 Million	CN¥606.02 Million ≈ $88.68 Million	+3.13pp
2017-12-31	5.04%	CN¥28.96 Million ≈ $4.24 Million	CN¥574.72 Million ≈ $84.10 Million	-6.53pp
2016-12-31	11.56%	CN¥60.00 Million ≈ $8.78 Million	CN¥518.85 Million ≈ $75.92 Million	-18.20pp
2015-12-31	29.76%	CN¥154.80 Million ≈ $22.65 Million	CN¥520.15 Million ≈ $76.11 Million	--

pp = percentage points

About Guangzhou Boji Medical and Biotechnological Co Ltd

SHE:300404 China Biotechnology

Market Cap

$671.16 Million

CN¥4.59 Billion CNY

Market Cap Rank

#10467 Global

#2775 in China

Share Price

CN¥11.89

Change (1 day)

+7.70%

52-Week Range

CN¥8.29 - CN¥17.60

All Time High

CN¥297.35